行情

ZTS

ZTS

硕腾
NYSE

实时行情|Nasdaq Last Sale

186.62
+0.02
+0.01%
盘后: 186.62 0 0.00% 16:39 06/22 EDT
开盘
186.53
昨收
186.60
最高
187.00
最低
185.88
成交量
141.66万
成交额
--
52周最高
187.32
52周最低
131.28
市值
886.01亿
市盈率(TTM)
50.31
分时
5日
1月
3月
1年
5年
The Daily Biotech Pulse:赛诺菲、Translate Bio 启动早期季节性流感疫苗研究,Reddy 博士推出通用型 Vascepa,Halozyme 达成许可交易
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21)
Benzinga · 17小时前
Elanco 达成交易以在宠物皮肤病学领域更好地与竞争对手 Zoetis 竞争
Elanco Animal Health said it struck a $440 million deal to acquire Kindred Biosciences, a move that will bolster its drug pipeline, particularly the fast-growing pet dermatology segment.
Barrons.com · 6天前
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15)
Benzinga · 6天前
每日生物技术脉搏:阿斯利康、百健面临临床试验失望、Novavax 研究冠状病毒-流感组合疫苗、武田的决定日
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14)
Benzinga · 06/15 12:07
The Daily Biotech Pulse:Vertex Shelves 中期研究,Precigen & Novan Jump On Data,血液学会议,Janux 首次亮相
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10)
Benzinga · 06/11 12:05
周四触及 52 周高点的股票
  Before 10 a.m. ET on Thursday, 258 companies set new 52-week highs.
Benzinga · 06/10 14:18
微软、雪佛龙和摩根大通将加拿大皇家银行列为对冲基金最受欢迎的股票
CNBC's "Halftime Report" traders discuss RBC's new list of most-popular stocks among hedge funds.
CNBC.com · 06/08 16:58
研究警报:CFRA 降低对 Zoetis, Inc. 的看法,从强力买入中买入
MT Newswires · 06/08 10:43
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解ZTS最新的财务预测,通过ZTS每股收益,每股净资产,每股现金流等数据分析硕腾近期的经营情况,然后做出明智的投资选择。
分析师评级

20位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测ZTS价格均价为191.60,最高价位211.00,最低价为159.00。
EPS
机构持股
总机构数: 1,722
机构持股: 4.63亿
持股比例: 97.58%
总股本: 4.75亿
类型机构数股数
增持
593
2,175.50万
建仓
108
255.84万
减持
458
2,177.79万
平仓
105
113.71万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-0.42%
制药与医学研究
-0.24%
高管信息
Non-Executive Chairman/Independent Director
Michael McCallister
Non-Executive Chairman/Independent Director
Michael Mccallister
Chief Executive Officer/Director
Kristin Peck
Chief Financial Officer/Executive Vice President
Wetteny Joseph
Chief Human Resource Officer/Executive Vice President
Roxanne Lagano
Executive Vice President/Chief Information Officer
Wafaa Mamilli
Executive Vice President/General Counsel/Secretary
Heidi Chen
Executive Vice President
Timothy Bettington
Executive Vice President
Robert Kelly
Executive Vice President
Catherine Knupp
Independent Director
Frank D'Amelio
Executive Vice President
J. Michael McFarland
Executive Vice President
Abhay Nayak
Executive Vice President
Sherry Pudloski
Executive Vice President
Roman Trawicki
Independent Director
Paul Bisaro
Independent Director
Frank D'amelio
Independent Director
Sanjay Khosla
Independent Director
Antoinette Leatherberry
Independent Director
Gregory Norden
Independent Director
Louise Parent
Independent Director
Willie Reed
Independent Director
Linda Rhodes
Independent Director
Robert Scully
公告日期
每股分红
除权日期
2021/05/20
每股分红:USD 0.25
2021/07/20
2021/02/10
每股分红:USD 0.25
2021/04/20
2020/12/09
每股分红:USD 0.25
2021/01/19
2020/10/07
每股分红:USD 0.2
2020/10/20
2020/05/20
每股分红:USD 0.2
2020/07/16
2020/02/11
每股分红:USD 0.2
2020/04/16
2019/12/11
每股分红:USD 0.2
2020/01/16
2019/10/03
每股分红:USD 0.164
2019/10/21
2019/05/15
每股分红:USD 0.164
2019/07/18
2019/02/12
每股分红:USD 0.164
2019/04/17
2018/12/12
每股分红:USD 0.164
2019/01/17
2018/10/10
每股分红:USD 0.126
2018/11/19
2018/05/15
每股分红:USD 0.126
2018/07/19
2018/02/13
每股分红:USD 0.126
2018/04/19
2017/12/11
每股分红:USD 0.126
2018/01/18
2017/10/05
每股分红:USD 0.105
2017/11/08
2017/05/22
每股分红:USD 0.105
2017/06/13
2017/02/15
每股分红:USD 0.105
2017/04/04
2016/12/07
每股分红:USD 0.105
2017/01/18
2016/10/06
每股分红:USD 0.095
2016/11/01
ZTS 简况
Zoetis Inc.主要从事畜牧动物及宠物的保健药物及疫苗的探索、开发、制造及商业化业务。该公司出售的产品针对八种动物,包括牛、猪、禽类、羊及鱼等畜牧动物以及狗、猫及马等宠物。其产品包括抗感染药、疫苗、驱虫剂、药物性饲料添加剂及其他医药。该公司通过两大部门运营:美国部门及国际部门。这些部门为畜牧动物饲主及宠物饲主提供多元化的产品组合。此外,其客户供给服务(CSS)机构为第三方提供合同制造服务。其还提供其他产品,如:营养品及农业产品。

微牛提供Zoetis Inc(NYSE-ZTS)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ZTS股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ZTS股票基本功能。